Dr. Jason Tan
Consultant Psychiatrist, Medical Director at Cygnet Health Care
MD (Moscow), PGDipAVMED (Otago), MRCPsych, MP (Melb)
Dr. Jason Tan is a UK-based consultant psychiatrist with over a decade of clinical practice across Malaysia, the Republic of Ireland and the UK. He is accredited by the Royal College of Psychiatrists as a specialist in General Adult Psychiatry with additional endorsement in Liaison Psychiatry. He completed his higher psychiatric training under the Maudsley Training Programme at South London and Maudsley NHS Foundation Trust — the institution that produced the Maudsley Deprescribing Guidelines, the operational manual this calculator is built on — and served there as a Consultant Liaison Psychiatrist before becoming Medical Director at Cygnet Health Care in 2024. Dr. Tan has published peer-reviewed research on community mental-health team effectiveness, family functioning and inpatient admission, and metabolic care for patients on long-term psychotropic medication; his work was recognised with the John Dunne Medal for excellence and originality in psychiatric research (Irish Journal of Psychological Medicine, 2019) and the RCPsych London Division Team of the Year award (2022). He advises Claro on the clinical accuracy of the tapering calculator, the framing of withdrawal vs. relapse, and the appropriate use of liquid and compounded formulations.
Affiliations
- CurrentCygnet Health Care — Medical Director
- CurrentDementech Neurosciences — Consultant Psychiatrist
- PastSouth London and Maudsley NHS Foundation Trust — Consultant Liaison Psychiatrist (former)
Training
- University of Melbourne — Master of Psychiatry (2019)
- The Royal College of Psychiatrists — MRCPsych (2018)
- University of Otago — Postgraduate Diploma in Aviation Medicine (PGDipAvMed) (2015)
- First Moscow State Medical University (Sechenov) — Doctor of Medicine (M.D.) (2008)
Awards
- John Dunne Medal — Irish Journal of Psychological Medicine (2019)
- Team of the Year — London Division — Royal College of Psychiatrists (2022)
- Excellent Service Award — Human Resource Development Panel, Sarawak State Health Department (2017)
Areas of expertise
- Antidepressant deprescribing
- Hyperbolic tapering
- Withdrawal syndromes
- General adult psychiatry
- Liaison psychiatry
- Neuropsychiatric and neurodevelopmental conditions
- Mood and anxiety disorders
- Psychopharmacology
Selected publications
- The effectiveness of community mental health teams in relation to team cohesion, authentic leadership and size of the team: a study in the North West of Ireland. Community Mental Health Journal 2022. doi:10.1007/s10597-022-00951-9
- Is the behavioral component in the Family Assessment Device uni- or multidimensional?. PsyCh Journal 2019. doi:10.1002/pchj.326
- The association between family dysfunction and admission to an acute mental health inpatient unit: a prospective study. Irish Journal of Psychological Medicine 2019. doi:10.1017/ipm.2019.41
- Establishing a dedicated metabolic clinic for patients with chronic mental illness. Irish Journal of Psychological Medicine 2019. Link
- Clozapine and Polycythemia Rubra Vera: a rare side effect or a separate medical condition? A case report. Malaysian Journal of Psychiatry 2017. Link
- Depression — what causes it, how is it diagnosed, and what is the treatment?. 2018. Link
- Anxiety unveiled: symptoms, causes, and effective management. 2024. Link
Selected talks, podcasts and articles
- Depression — what causes it, how is it diagnosed, and what is the treatment? — Top Doctors UK (2018)
- Anxiety unveiled: symptoms, causes, and effective management — Top Doctors UK (2024)
Reviewed at Claro
- Hero + clinical framing
- Pre-taper risk assessment criteria
- Symptom validator clinical messaging
- Withdrawal vs. relapse guidance
- Liquid and compounded formulation copy